Search

Your search keyword '"Shayne, Michelle"' showing total 181 results

Search Constraints

Start Over You searched for: Author "Shayne, Michelle" Remove constraint Author: "Shayne, Michelle"
181 results on '"Shayne, Michelle"'

Search Results

5. A Whole-Food, Plant-Based Randomized Controlled Trial in Metastatic Breast Cancer: Weight, Cardiometabolic, and Hormonal Outcome

7. Data from Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression

8. Supplementary Figure 2 from Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression

9. Supplementary Figure 1 from Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression

10. Supplementary Figure Legends 1-2 from Heat Shock Protein 27 Differentiates Tolerogenic Macrophages That May Support Human Breast Cancer Progression

11. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX® Testing

15. The Effects of a Mediterranean Diet Intervention on Cancer-Related Fatigue for Patients Undergoing Chemotherapy: A Pilot Randomized Controlled Trial

17. Strategies for Improving Access to Cancer Services in Rural Communities: A Pre-implementation Study

19. Serum Proteome Profiling Detects Myelodysplastic Syndromes and Identifies CXC Chemokine Ligands 4 and 7 as Markers for Advanced Disease

20. Abstract P4-06-07: Clinical risk-assessment, risk-stratification, and outcomes of ER positive, HER2 negative breast cancer patients using the Rochester modified Magee algorithm (RoMMA)

22. The Rochester Modified Magee Algorithm (RoMMa): An Outcomes Based Strategy for Clinical Risk-Assessment and Risk-Stratification in ER Positive, HER2 Negative Breast Cancer Patients Being Considered for Oncotype DX ® Testing.

24. Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

25. The City Symbiotic: Integrating Architecture and Hydrology in the Public Realm

27. Phase II study of exercise and low-dose ibuprofen for cancer-related cognitive impairment (CRCI) during chemotherapy.

29. Abstract PS6-18: Are we missing something? Ki-67 evaluation is important in African American women with an oncotype DX score< 26: A multi-institutional study

30. Abstract PS6-24: Are we missing something? Increased recurrence rates in patients with an oncotype DX score < 26 and a modified magee score > 18: A multi-institutional study

31. The association between cancer-related fatigue and diabetes from pre-chemotherapy to 6-months post-chemotherapy

35. Prognosis

36. Applying Implementation and Team Science Principles to Facilitate Cancer Program Implementation in Remote, Under-resourced Areas

40. Risk stratification of ER‐positive breast cancer patients: A multi‐institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX®recurrence score <26

41. A phase II RCT of high-dose vitamin D supplementation and exercise for cancer treatment-induced bone loss in breast cancer patients on aromatase inhibitors.

42. The effect of structured exercise during chemotherapy on chemotherapy-induced peripheral neuropathy (CIPN): A role for interoceptive brain circuitry.

45. Decision aids and health information technology: One size does not fit all.

46. An integrative approach to personalized cancer survivorship care at an academic medical center.

47. Risk stratification of ER‐positive breast cancer patients: A multi‐institutional validation and outcome study of the Rochester Modified Magee algorithm (RoMMa) and prediction of an Oncotype DX® recurrence score <26.

Catalog

Books, media, physical & digital resources